--- title: Buy Januvia (Sitagliptin) 50mg, 100mg Pills Online description: Januvia (Sitagliptin) 50mg and 100mg pills are a trusted choice for managing type 2 diabetes. Order from our secure online pharmacy for reliable delivery. type: product language: en url: https://medsforsale.net/buy-januvia-online-en availability: in_stock price_min: 44.99 price_max: 359.99 currency: USD offers: - name: 50mg x 10 pills price: 44.99 - name: 50mg x 20 pills price: 85.99 - name: 50mg x 30 pills price: 125.99 - name: 50mg x 40 pills price: 159.99 - name: 50mg x 60 pills price: 221.99 - name: 50mg x 90 pills price: 321.99 - name: 100mg x 10 pills price: 49.99 - name: 100mg x 20 pills price: 94.99 - name: 100mg x 30 pills price: 134.99 - name: 100mg x 40 pills price: 172.99 - name: 100mg x 60 pills price: 248.99 - name: 100mg x 90 pills price: 359.99 --- # Buy Januvia (Sitagliptin) 50mg, 100mg Pills Online Januvia, containing the active ingredient Sitagliptin, is a highly effective dipeptidyl peptidase-4 (DPP-4) inhibitor originally developed by Merck & Co. It is used to improve blood sugar control in adults with type 2 diabetes by increasing insulin levels after meals. It is designed for patients looking for a dependable daily management tool. Our pharmacy provides a convenient and secure way to buy Januvia in 50mg and 100mg pills. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **50mg** | 10 pills | **$44.99** | $4.50 | In Stock | | **50mg** | 20 pills | **$85.99** | $4.30 | In Stock | | **50mg** | 30 pills | **$125.99** | $4.20 | In Stock | | **50mg** | 40 pills | **$159.99** | $4.00 | In Stock | | **50mg** | 60 pills | **$221.99** | $3.70 | In Stock | | **50mg** | 90 pills | **$321.99** | $3.58 | In Stock | | **100mg** | 10 pills | **$49.99** | $5.00 | In Stock | | **100mg** | 20 pills | **$94.99** | $4.75 | In Stock | | **100mg** | 30 pills | **$134.99** | $4.50 | In Stock | | **100mg** | 40 pills | **$172.99** | $4.32 | In Stock | | **100mg** | 60 pills | **$248.99** | $4.15 | In Stock | | **100mg** | 90 pills | **$359.99** | $4.00 | In Stock | [Buy Now](https://medsforsale.net/buy-januvia-online-en) ## Introduction Januvia is a prescription medication that contains the active ingredient sitagliptin phosphate. It belongs to the class of dipeptidyl-peptidase-4 (DPP-4) inhibitors, a group of oral agents used to improve blood-glucose control in adults with type 2 diabetes mellitus (T2DM). Januaria is available as a tablet in strengths of 50 mg and 100 mg. The drug is produced by Merck & Co. and is approved for use as monotherapy or in combination with other antihyperglycemic agents. In addition to its primary indication, clinical research has examined sitagliptin for several secondary and off-label applications, though these uses remain unapproved by regulatory agencies. ## What is Januvia? Januvia is the branded formulation of sitagliptin phosphate, a selective DPP-4 inhibitor. Developed by Merck & Co., it received U.S. FDA approval in 2006 for the treatment of type 2 diabetes. Sitagliptin is also marketed under other brand names such as Januvia, Janumet (combined with metformin), and Glyxambi (combined with empagliflozin). The medication is supplied as a film-coated tablet intended for oral administration once daily, with or without food. ## How Januvia Works Sitagliptin blocks the enzyme dipeptidyl-peptidase-4, which normally degrades the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). By inhibiting DPP-4, higher circulating levels of GLP-1 and GIP persist after meals. These hormones stimulate pancreatic β-cells to release insulin in a glucose-dependent manner and suppress glucagon secretion from α-cells. The net effect is reduced post-prandial glucose excursions without causing hypoglycaemia when used alone. Sitagliptin has a half-life of approximately 12 hours, allowing steady plasma concentrations with a once-daily dose. It is eliminated primarily unchanged in the urine; therefore, renal function guides dose adjustments. ## Conditions Treated with Januvia - **Type 2 Diabetes Mellitus (T2DM)** - Approved as monotherapy or as an add-on to metformin, sulfonylureas, thiazolidinediones, or insulin. The drug improves glycated haemoglobin (HbA1c) by 0.5-.8 % on average, helping patients reach individualized glycaemic targets. - **Combination Therapy for T2DM** - Fixed-dose combinations such as Janumet (sitagliptin + metformin) provide convenient dual therapy for patients who require both agents to achieve control. Januvia is not approved for type 1 diabetes, gestational diabetes, or pre-diabetes. ## Off-Label and Investigational Uses of Januvia - **Prediabetes and Impaired Glucose Tolerance** - Small randomized trials have explored sitagliptin to delay progression to overt T2DM. While some studies reported modest reductions in fasting glucose, regulatory bodies have not granted indication for this use. - **Non-Alcoholic Fatty Liver Disease (NAFLD)** - Early-phase research indicates that DPP-4 inhibition may improve hepatic steatosis markers, but evidence remains limited and safety in this population is not established. - **Cardiovascular Risk Modification** - Post-hoc analyses of large outcomes trials (e.g., SAVOR-TIMI 53) examined sitagliptin’s impact on major adverse cardiovascular events. Results showed neutral effects on cardiovascular mortality, but the drug is not approved for primary cardiovascular prevention. - **Polycystic Ovary Syndrome (PCOS)** - Some investigators have tested sitagliptin for insulin resistance in PCOS, noting improvements in androgen levels. These findings are preliminary and not endorsed by the FDA or EMA. All off-label applications should be pursued only under direct supervision of a qualified healthcare provider who can assess benefit-risk balance. ## Is Januvia the Right Medication for You? Januvia is suitable for adults with type 2 diabetes whose blood-glucose levels are inadequately controlled by diet, exercise, or metformin alone. It is particularly helpful when clinicians wish to avoid hypoglycaemia and weight gain, as sitagliptin is weight-neutral and has a low intrinsic risk of causing low blood sugar. Patients with mild to moderate renal impairment (eGFR ≥ 30 mL/min/1.73 m²) may use the standard dose, while those with severe renal dysfunction require dose reduction. Contraindications include: known hypersensitivity to sitagliptin or any tablet excipient, and a history of pancreatitis. Caution is advised in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2, although a causal link has not been confirmed. ## Risks, Side Effects, and Interactions ### Common - Nasopharyngitis - Upper respiratory tract infection - Headache - Nausea These events are typically mild and resolve without intervention. ### Rare - Acute pancreatitis (characterized by severe abdominal pain, nausea, and vomiting) - Severe skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis Patients experiencing any of these symptoms should seek immediate medical attention. ### Serious - Persistent hypoglycaemia when combined with insulin or sulfonylureas (requires dose adjustment) - Anaphylaxis or angioedema in hypersensitive individuals Prompt emergency care is essential for serious allergic reactions. #### Drug-Drug Interactions - **Insulin or sulfonylureas** - May increase risk of hypoglycaemia; dose reductions of the concomitant agents are often necessary. - **Strong CYP3A4 inhibitors/inducers** - Sitagliptin is not a major CYP substrate, but co-administration with drugs that affect renal tubular secretion (e.g., probenecid) can raise sitagliptin concentrations. - **Rifampin** - May lower sitagliptin exposure; monitoring of glycaemic control is recommended. #### Drug-Food Interactions Sitagliptin can be taken with or without meals; no specific food restrictions are required. Alcohol does not alter its pharmacokinetics but excessive intake can impair glucose regulation. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** - 100 mg once daily for patients with normal renal function. For eGFR 30-45 mL/min/1.73 m², reduce to 50 mg daily; for eGFR 15-30 mL/min/1.73 m², use 25 mg daily. - **Missed dose** - Take the missed tablet as soon as remembered unless the time for the next dose is near. Do not double-dose to compensate. - **Overdose** - Symptoms may include nausea, vomiting, or severe hypoglycaemia when combined with insulin. Seek emergency medical care; supportive measures such as monitoring blood glucose and intravenous dextrose are standard. Sitagliptin tablets should be swallowed whole with water. No special timing with respect to meals is required, but maintaining a consistent daily schedule enhances adherence. Patients should avoid operating heavy machinery until they know how the medication affects them, especially during the first few days. ## FAQ - **What should I do if I travel internationally with Januvia?**   Carry the medication in its original packaging with a copy of the prescription label. Keep tablets in a temperature-controlled environment; avoid exposure to extreme heat or humidity, which can degrade the film coating. - **Are there differences between the 50 mg and 100 mg tablets in appearance?**   Yes. The 50 mg tablet is typically round and lightly coloured, while the 100 mg tablet is larger and may have a distinct hue or imprint. The exact look can vary by manufacturer, so verify the imprint code before use. - **Can sitagliptin affect laboratory tests for kidney function?**   Sitagliptin is primarily excreted unchanged in urine and does not interfere with standard serum creatinine or eGFR measurements. However, abrupt changes in renal clearance can alter drug exposure, so periodic kidney monitoring is advisable. - **Is it safe to use Januvia in patients with mild liver disease?**   Sitagliptin undergoes minimal hepatic metabolism, and clinical data show no dose adjustment is required for mild to moderate hepatic impairment. Severe liver disease has not been studied extensively; clinicians should exercise caution. - **How long does it take to see a reduction in HbA1c after starting Januvia?**   Reductions in HbA1c are generally observed after 12 weeks of consistent therapy. Individual response may vary based on baseline glucose control, adherence, and concurrent medications. - **Does Januvia interact with over-the-counter supplements such as berberine?**   Berberine can modestly lower blood glucose and may increase the risk of hypoglycaemia when combined with sitagliptin. Patients should inform their healthcare provider before adding such supplements. - **Can pregnant or nursing women use sitagliptin?**   Sitagliptin is classified as Pregnancy Category B (US) and is not recommended during pregnancy or lactation unless the potential benefit justifies the potential risk. Alternative agents with established safety profiles are preferred. - **What is the shelf life of a Januvia tablet after opening the bottle?**   Tablets remain stable until the expiration date printed on the packaging, provided they are stored in a dry, cool place and the container remains sealed. Do not use tablets that appear discoloured or fragmented. - **Do DPP-4 inhibitors like sitagliptin affect cardiovascular outcomes?**   Large cardiovascular outcome trials (e.g., SAVOR-TIMI 53) demonstrated that sitagliptin does not increase major adverse cardiovascular events compared with placebo, establishing cardiovascular safety but not superiority. - **Are there any special disposal instructions for unused Januvia?**   Unused tablets should be placed in a sealed container and disposed of through a medication take-back program or as instructed by local pharmacy waste regulations. Do not flush tablets down the toilet. - **Why might my blood glucose readings be higher on some days despite taking Januvia regularly?**   Factors such as dietary indiscretion, stress, illness, or temporary changes in renal function can affect glucose levels independently of medication adherence. Continuous monitoring and lifestyle adjustments are essential for optimal control. - **Is there a generic version of sitagliptin available?**   Yes, sitagliptin is marketed as a generic oral tablet identical in strength and formulation to the branded product. Generic options are typically less expensive while maintaining FDA-approved bioequivalence. ## Glossary **DPP-4 Inhibitor** : A class of oral antidiabetic drugs that block the enzyme dipeptidyl-peptidase-4, thereby prolonging the action of incretin hormones which regulate insulin and glucagon secretion. **HbA1c (Glycated Hemoglobin)** : A blood test reflecting average glucose levels over the preceding 2-3 months; used to assess long-term diabetes control. **eGFR (Estimated Glomerular Filtration Rate)** : A calculated measure of kidney function based on serum creatinine, age, sex, and race, guiding dosage adjustments for renally cleared medications. **Incretin Hormones** : Gut-derived peptides (primarily GLP-1 and GIP) that enhance insulin release after meals in a glucose-dependent manner. ## Buying Januvia from [our online pharmacy](https://medsforsale.net/buy-januvia-online-en) Patients who encounter cost barriers, limited local pharmacy stock, or insurance restrictions can obtain sitagliptin tablets through [our online pharmacy](https://medsforsale.net/buy-januvia-online-en). We source the medication directly from licensed, international suppliers that meet stringent quality-assurance standards, ensuring each batch matches the composition of the FDA-approved product. Because we purchase near the manufacturer’s price, the cost to the patient is considerably lower than typical retail rates. Discreet packaging and a secure checkout protect privacy, while our logistics partners provide reliable delivery-express options within 7 days and regular airmail in roughly 3 weeks, with tracking available for every order. Our service operates as a pharmacy-broker model, collaborating with verified overseas pharmacies to expand access to essential medicines. This structure enables us to offer a cost-effective, confidential solution for individuals who might otherwise face delays or prohibitive expenses. ## Disclaimer The information presented about Januvia is intended for general educational purposes and does not substitute professional medical advice. Treatment decisions, including any off-label applications, must be made under the guidance of a qualified healthcare professional. Readers are presumed to be responsible adults capable of making informed health choices. [our online pharmacy](https://medsforsale.net/buy-januvia-online-en) provides access to Januvia for those who may encounter limited availability through conventional pharmacies, insurance formularies, or who are seeking affordable generic alternatives. Always discuss with your clinician before initiating, modifying, or stopping any medication.